Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. MOULIN (Grenoble, France), M. Pauly (Grenoble, France), A. Thomas (Los Angeles, United States of America), M. Detrait (Grenoble, France), G. Vial (Grenoble, France), F. Lamarche (Grenoble, France), H. Dubouchaud (Grenoble, France), C. Arnaud (Grenoble, France), D. Godin-Ribuot (Grenoble, France), E. Belaidi-Corsat (Grenoble, France). Intermittent hypoxia, the hallmark of sleep apnea, induces HIF-1-dependent mitochondrial dysfunction. 3285

Member's Comments

No comment yet.

Related content which might interest you: Intermittent hypoxia in sleep apnea: a cause of inflammatory activation Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 Relationship of oxidative stress and endothelial dysfunction in sleep apnoea Source: Eur Respir J 2011; 37: 873-879 Year: 2011 Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea Source: Eur Respir J 2011; 39: 215-217 Year: 2012 Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea Source: Eur Respir J 2012; 39: 215-217 Year: 2012 Chronic intermittent hypoxia mimicking sleep apnoea increases spontaneous tumorigenesis in mice Source: Eur Respir J , 49 (2) 1602111; DOI: 10.1183/13993003.02111-2016 Year: 2017 Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009 Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea Source: Eur Respir J 2011; 37: 89-97 Year: 2011 Chronic intermittent hypoxia reduces progressive sperm motility in a mouse model of obstructive sleep apnea Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013 Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006 Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea Source: Eur Respir J, 50 (4) 1700833; 10.1183/13993003.00833-2017 Year: 2017 Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives Source: Eur Respir J 2008; 32: 1082-1095 Year: 2008 A simple device to subject cells to intermittent hypoxia mimicking obstructive sleep apnea Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Hypoxic and non-hypoxic obstructive sleep disordered breathing. Effect on cytotoxic lymphocytes and metabolic parameters Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016 Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia Source: Eur Respir J 2012; 39: 1492-1500 Year: 2012 Can the nocturnal apnoea increase the oxidative stress in OSA patients? Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002 Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Source: Eur Respir J , 49 (4)  1601731; DOI: 10.1183/13993003.01731-2016 Year: 2017